You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

r/r IL

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Plus Serum Levels of IL23 and IL17A to Rheumatoid Arthritis

Not yet recruiting
  • Rheumatoid Arthritis
    • (no location specified)
    Oct 4, 2022

    Immunophenotypic Evaluation of IL-7R a in Acute Leukaemia

    Not yet recruiting
    • Benefit: To Patient Have Investigation for Diagnosis and Follow up for His Disease and Reach to New Method Help in Early Diagnosis of Lymphoid Disorder
      • (no location specified)
      Nov 30, 2022

      IL-5R Signaling in Non-eosinophil Upper Airway Cells in CRSwNP

      Recruiting
      • Nasal Polyps
      • Aspirin-exacerbated Respiratory Disease
      • Non-Interventional
      • Boston, Massachusetts
        Brigham and Women's Hospital
      Jan 5, 2023

      IL-4R Monoclonal Antibody for Chronic Rhino-sinusitis With

      Not yet recruiting
      • Chronic Rhino-sinusitis
      • +3 more
      • IL-4R
      • Placebo
      • Beijing, Beijing, China
        Beijing Tongren Hospital, Capital Medical University
      Jun 17, 2022

      Rheumatoid Arthritis Trial in China (IL-6R Monoclonal Antibody Injection 4mg/kg, IL-6R Monoclonal Antibody Injection 6mg/kg,

      Completed
      • Rheumatoid Arthritis
      • IL-6R Monoclonal Antibody Injection 4mg/kg
      • +3 more
      • Baoding, China
      • +4 more
      Feb 24, 2022

      Increased Disease Severity in AD the IL-4Ra R576 Polymorphism

      Recruiting
      • Atopic Dermatitis
        • Boston, Massachusetts
          Boston Children's Hospital
        Jun 5, 2022

        Glioblastoma Trial in Gainesville (Ex-Vivo expanded autologous IL-8 receptor (CXCR2) modified CD70 CAR (8R-70CAR) T cells)

        Not yet recruiting
        • Glioblastoma
        • Ex-Vivo expanded autologous IL-8 receptor (CXCR2) modified CD70 CAR (8R-70CAR) T cells
        • Gainesville, Florida
          University of Florida Health
        Jul 29, 2022

        Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome, Recurrent Chronic Myelomonocytic Leukemia Trial in Houston

        Recruiting
        • Chronic Myelomonocytic Leukemia
        • +5 more
        • Canakinumab
        • Houston, Texas
          M D Anderson Cancer Center
        Dec 7, 2022

        Interleukin-6 Inhibition, Physical Stress, Appetitive Behavior Trial in Copenhagen Ø (Tocilizumab Injectable Product, Saline

        Completed
        • Interleukin-6 Inhibition
        • +2 more
        • Tocilizumab Injectable Product
        • Saline 0.9% 100 ml NaCl 0.9% will be infused over 1 hour
        • Copenhagen Ø, Denmark
          Center For Physical Activity (CFAS)
        Aug 19, 2022

        Recurrent B-Cell Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood B-Lymphoblastic Lymphoma Trial in San Diego,

        Completed
        Has Results
        • Recurrent B-Cell Childhood Acute Lymphoblastic Leukemia
        • Recurrent Childhood B-Lymphoblastic Lymphoma
        • San Diego, California
        • +2 more
        Sep 13, 2022

        Acute Myeloid Leukemia Trial in Los Angeles, San Francisco (Azacitidine, Tagraxofusp-erzs)

        Not yet recruiting
        • Acute Myeloid Leukemia
        • Los Angeles, California
        • +1 more
        Jan 31, 2023

        Asthma Trial in Ann Arbor (Dupilumab)

        Recruiting
        • Asthma
        • Ann Arbor, Michigan
          University of Michigan
        Mar 3, 2022

        R/R CD19-Positive B-Cell Malignancies, Indolent Non-Hodgkin Lymphoma, Aggressive Non-Hodgkin Lymphoma Trial (CNTY-101, IL-2,

        Recruiting
        • R/R CD19-Positive B-Cell Malignancies
        • +2 more
        • CNTY-101
        • +2 more
        • Detroit, Michigan
        • +1 more
        Dec 21, 2022

        Pneumococcal Vaccines Trial in Canada (IVT PCV-25 Formulation A, IVT PCV-25 Formulation B, IVT PCV-25 Formulation C)

        Not yet recruiting
        • Pneumococcal Vaccines
        • IVT PCV-25 Formulation A
        • +3 more
        • Vancouver, British Columbia, Canada
        • +3 more
        Oct 10, 2023

        Idiopathic Multicentric Castleman's Disease Trial in Beijing, Chengdu (Recombinant Humanized Anti-interleukin-6 Receptor

        Recruiting
        • Idiopathic Multicentric Castleman's Disease
        • Recombinant Humanized Anti-interleukin-6 Receptor Monoclonal Antibody Injection 4mg/kg
        • +2 more
        • Beijing, China
        • +2 more
        Apr 26, 2022

        Allogeneic Stem Cell Transplant Recipient, Blasts 10 Percent or More of Bone Marrow Nucleated Cells, Recurrent Acute Myeloid

        Recruiting
        • Allogeneic Stem Cell Transplant Recipient
        • +3 more
        • Cytarabine Hydrochloride
        • +2 more
        • Columbus, Ohio
          Ohio State University Comprehensive Cancer Center
        Feb 7, 2022

        Blastic Plasmacytoid Dendritic Cell Tumor Trial in Houston (Tagraxofusp-erzs)

        Active, not recruiting
        • Blastic Plasmacytoid Dendritic Cell Neoplasm
        • Tagraxofusp-erzs
        • Houston, Texas
          M D Anderson Cancer Center
        Apr 8, 2022

        Chronic GVHD Trial in Duarte (biological, procedure, other)

        Active, not recruiting
        • Chronic Graft Versus Host Disease
        • Aldesleukin
        • +3 more
        • Duarte, California
          City of Hope Medical Center
        Jan 4, 2023

        Anti-IL-6 Receptor Monoclonal Antibodies on Treatment of

        Recruiting
        • Rheumatoid Arthritis
        • +3 more
          • Barcelona, Spain
            Hospital de la Santa Creu i Sant Pau
          Apr 25, 2022

          NSCLC, Non-Small Cell Lung Carcinoma, NSCLC Trial run by the National Cancer Institute (NCI) (biological, drug, device)

          Not yet recruiting
          • Non-Small Cell Lung Cancer
          • +3 more
          • Montanide (Registered Trademark) ISA-51 VG Adjuvant
          • +3 more
          • Bethesda, Maryland
            National Institutes of Health Clinical Center
          Feb 2, 2023

          Kidney Transplantation, Kidney Diseases, Kidney Failure Trial in London (Campath, Daclizumab)

          Completed
          Has Results
          • Kidney Transplantation
          • +2 more
          • London, United Kingdom
            West London Renal and Transplant Centre, 4th Floor Ham House, Ha
          Sep 1, 2021

          Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8 Trial in Atlanta (Aldesleukin,

          Not yet recruiting
          • Lung Non-Small Cell Carcinoma
          • +3 more
          • Aldesleukin
          • Pembrolizumab
          • Atlanta, Georgia
            Emory University/Winship Cancer Institute
          Aug 8, 2022

          Recurrent DLBCL, Recurrent DLBCL, Not Otherwise Specified, Recurrent Grade 3b Follicular Lymphoma Trial in Seattle

          Recruiting
          • Recurrent Diffuse Large B-Cell Lymphoma
          • +8 more
          • Seattle, Washington
            Fred Hutch/University of Washington Cancer Consortium
          Dec 30, 2022

          Healthy Trial in Auckland (Recombinant Humanized Anti-IL-36R Monoclonal antibody and Placebo)

          Not yet recruiting
          • Healthy
          • Recombinant Humanized Anti-IL-36R Monoclonal antibody and Placebo
          • Auckland, New Zealand
            New zealand Clinical Research
          Jul 14, 2022

          Generalized Pustular Psoriasis Trial in Shandong (HB0034)

          Not yet recruiting
          • Generalized Pustular Psoriasis
          • Shandong, Shandong, China
            Shandong Provincial Dermatology Hospital
          Aug 22, 2022